Ali Ahmed, MD, MPH, Michael W. Rich, MD, Michael Zile, MD, Paul W

Slides:

Advertisements

Similar presentations

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Advertisements

Rate-control versus Rhythm-control Strategies and Outcomes in Septuagenarians with Atrial Fibrillation Nasir Shariff, MD, Ravi V. Desai, MD, Kanan Patel,

Volume 82, Issue 12, Pages (December 2012)

Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E

Urine Potassium Excretion, Kidney Failure, and Mortality in CKD

Volume 146, Issue 5, Pages (November 2014)

Effect of Renin-Angiotensin System Blockade on Calcium Channel Blocker-Associated Peripheral Edema Harikrishna Makani, MD, Sripal Bangalore, MD, MHA,

Hypertension Awareness, Treatment, and Control in Chronic Kidney Disease Pantelis A. Sarafidis, MD, PhD, Suying Li, PhD, Shu-Cheng Chen, MS, Allan J.

Isolated Systolic Hypertension: An Update After SPRINT

Alexander A. Leung, MD, MPH, Finlay A. McAlister, MD, MSc, Samuel R. G

Diabetic Kidney Disease: An ACEI (or an ARB) in the Hole

Early Invasive Versus Initial Conservative Strategies for Women with Non–ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis Islam Y. Elgendy,

Frederic Rahbari-Oskoui, MD, MS American Journal of Kidney Diseases

Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure

30-Day Readmissions After an Acute Kidney Injury Hospitalization

Digoxin Use and Lower 30-day All-cause Readmission for Medicare Beneficiaries Hospitalized for Heart Failure Ali Ahmed, MD, MPH, Robert C. Bourge, MD,

Thinking Beyond New Clinical Guidelines: Update in Hypertension

Treatment of Early Immunoglobulin A Nephropathy by Angiotensin-converting Enzyme Inhibitor Philip Kam-Tao Li, MD, Bonnie Ching-Ha Kwan, MBBS, Kai-Ming.

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical.

Jessica W. Weiss, MD, Eric S. Johnson, PhD, Amanda Petrik, MS, David H

Outcomes with Angiotensin-converting Enzyme Inhibitors vs Other Antihypertensive Agents in Hypertensive Blacks Sripal Bangalore, MD, MHA, Gbenga Ogedegbe,

Body Mass Index and Mortality in Acute Myocardial Infarction Patients

The Impact of Race on the Prognosis of Preclinical Diastolic Dysfunction: A Large Multiracial Urban Population Study Jian Shan, MD, Lili Zhang, MD, MSc,

Sabina Hunziker, MD, MPH, Jennifer Stevens, MD, MS, Michael D

Age and Gender Differences in Quality of Care and Outcomes for Patients with ST- segment Elevation Myocardial Infarction Sripal Bangalore, MD, MHA, Gregg.

Intensive Hemodialysis and Health-Related Quality of Life

Rate-control versus Rhythm-control Strategies and Outcomes in Septuagenarians with Atrial Fibrillation Nasir Shariff, MD, Ravi V. Desai, MD, Kanan Patel,

Aortic anatomic severity grade correlates with resource utilization

Patient and Graft Survival Following Kidney Transplantation in Recipients With Cystinosis: A Cohort Study Rebecca A. Spicer, MBChB, Philip A. Clayton,

Preventing and Treating Acute Kidney Injury Among Hospitalized Patients with Cirrhosis and Ascites: A Narrative Review Elliot B. Tapper, MD, Alan Bonder,

Characteristics of Contemporary Patients Discharged From the Hospital After an Acute Coronary Syndrome Robert J. Goldberg, PhD, Jane S. Saczynski, PhD,

Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study Vasilios Papademetriou, MD, DSc, Eric.

Volume 82, Issue 12, Pages (December 2012)

Impact of Preoperative Angiotensin-Converting Enzyme Inhibitor Use on Clinical Outcomes After Cardiac Surgery Maral Ouzounian, MD, Karen J. Buth, MS,

Acute Kidney Injury and Death Associated With Renin Angiotensin System Blockade in Cardiothoracic Surgery: A Meta-analysis of Observational Studies Rabi.

Your Kidneys May Outlive You

Nat. Rev. Cardiol. doi: /nrcardio

The Impact of Prior Heart Failure Hospitalizations on Long-term Mortality Differs by Baseline Risk of Death Naga V.A. Kommuri, MD, Todd M. Koelling,

The Natural Course of Microalbuminuria among African Americans with Type 2 Diabetes: A 3-Year Study Mohamed G. Atta, MD, MPH, Kesha Baptiste-Roberts,

Audit-based education: a potentially effective program for improving guideline achievement in CKD patients Moniek C.M. de Goeij, Joris I. Rotmans Kidney.

Molly E. Waring, PhD, Jane S

Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016 Murray Epstein, MD, Daniel A. Duprez,

Volume 94, Issue 3, Pages (September 2018)

Ioannis Koulouridis, MD, MS, Lori Lyn Price, MAS, Nicolaos E

Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical.

CKD and the Risk of Acute, Community-Acquired Infections Among Older People With Diabetes Mellitus: A Retrospective Cohort Study Using Electronic Health.

Kidney Disease End Points in a Pooled Analysis of Individual Patient–Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor.

Polyunsaturated Fatty Acids and Kidney Disease

Beef Tea, Vitality, Creatinine, and the Estimated GFR

Does Methylphenidate Reduce the Symptoms of Chronic Fatigue Syndrome?

Study Designs in Patient-Oriented Research

Jennifer Tjia, MD, MSCE, Jeroan Allison, MD, Jane S

Shannon M. Dunlay, MD, MS, Quinn R. Pack, MD, Randal J

Angiotensin-converting Enzyme Inhibitors and Outcomes in Heart Failure and Preserved Ejection Fraction Marjan Mujib, MD, MPH, Kanan Patel, MBBS, MPH,

Prevalence and Risk Factors for Erectile Dysfunction in the US

Effect of Spironolactone on Physical Performance in Older People with Self-reported Physical Disability Louise A. Burton, MD, Deepa Sumukadas, MD, Miles.

Rami Doukky et al. JCHF 2016;4:24-35

Effect of Renin-Angiotensin System Blockade on Calcium Channel Blocker-Associated Peripheral Edema Harikrishna Makani, MD, Sripal Bangalore, MD, MHA,

Statin Use and Risk of COPD Exacerbation Requiring Hospitalization

Ali Ahmed, MD, Gregg C. Fonarow, MD, Yan Zhang, MS, MSPH, Paul W

Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure Cherinne Arundel,

Isolated Systolic Hypertension: An Update After SPRINT

Cognitive Impairment in Older Adults with Heart Failure: Prevalence, Documentation, and Impact on Outcomes John A. Dodson, MD, Tuyet-Trinh N. Truong,

Comparative Superiority of ACE Inhibitors Over Angiotensin Receptor Blockers for People With CKD: Does It Matter? Dimitris Mavridis, PhD American Journal.

Volume 73, Issue 5, Pages (March 2008)

Off-pump bilateral skeletonized internal thoracic artery grafting in patients with chronic kidney disease Takeshi Kinoshita, MD, PhD, Tohru Asai, MD,

Ann M. O'Hare, MA, MD American Journal of Kidney Diseases

Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States Ahmet Ergin, MD, PhD, MPH, Paul.

Renin-angiotensin-aldosterone-system inhibition is safe in the preoperative period surrounding carotid endarterectomy Andrea M. Steely, MD, Peter W.

Presentation transcript:

Renin-Angiotensin Inhibition in Diastolic Heart Failure and Chronic Kidney Disease Ali Ahmed, MD, MPH, Michael W. Rich, MD, Michael Zile, MD, Paul W. Sanders, MD, Kanan Patel, MBBS, MPH, Yan Zhang, MS, MSPH, Inmaculada B. Aban, PhD, Thomas E. Love, PhD, Gregg C. Fonarow, MD, Wilbert S. Aronow, MD, Richard M. Allman, MD The American Journal of Medicine Volume 126, Issue 2, Pages 150-161 (February 2013) DOI: 10.1016/j.amjmed.2012.06.031 Copyright © 2013 Terms and Conditions

Figure 1 Love plots displaying absolute standardized differences for 56 baseline characteristics among older patients with diastolic heart failure and chronic kidney disease receiving versus not receiving discharge prescriptions for angiotensin-converting enzyme inhibitors or angiotensin receptor blockers before and after propensity score matching. The American Journal of Medicine 2013 126, 150-161DOI: (10.1016/j.amjmed.2012.06.031) Copyright © 2013 Terms and Conditions

Figure 2 Kaplan-Meier plot for all-cause mortality in a propensity-matched cohort of older patients with diastolic heart failure and chronic kidney disease receiving and not receiving discharge prescription of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. ACEI = angiotensin-converting enzyme inhibitor; ARB = angiotensin receptor blocker; CI = confidence interval. The American Journal of Medicine 2013 126, 150-161DOI: (10.1016/j.amjmed.2012.06.031) Copyright © 2013 Terms and Conditions

Figure 3 Association of discharge prescription of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers with all-cause mortality in subgroups of propensity-matched older patients with diastolic heart failure and chronic kidney disease. ACEI = angiotensin-converting enzyme inhibitor; ARB = angiotensin receptor blocker; CI = confidence interval; GFR = glomerular filtration rate. The American Journal of Medicine 2013 126, 150-161DOI: (10.1016/j.amjmed.2012.06.031) Copyright © 2013 Terms and Conditions